UnitedHealth Group (UNH) is the worst Dow Jones stock Thursday, putting pressure on the price-weighted index, after the health insurance company reported mixed results for its fourth quarter.
In the three months ending December 31, UnitedHealth's revenue increased 6.8% year over year to $100.8 billion, thanks in part to a 4.4% rise in premiums to $76.5 billion. Its earnings per share (EPS) were up 10.6% from the year-ago period to $6.81.
"The people of UnitedHealth Group remain focused on making high-quality, affordable healthcare more available to more people while making the health system easier to navigate for patients and providers, positioning us well for growth in 2025," said UnitedHealth CEO Andrew Witty in a statement.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
While the company's earnings topped the $6.72 per share that Wall Street was anticipating, UNH's revenue fell short of the $101.8 billion analysts called for, according to CNBC. This marks the first top-line miss for UnitedHealth since Q2 2020. Revenue from premiums also came in below expectations of $78.1 billion.
Additionally, UnitedHealth reaffirmed the 2025 outlook it provided last month, which calls for revenue in the range of $450 billion to $455 billion and earnings per share between $29.50 to $30.
Is UnitedHealth stock a buy, sell or hold?
UnitedHealth has underperformed the broad market over the past 12 months, up 6% on a total return basis (price change plus dividends) vs the S&P 500's 26% gain. But Wall Street remains overwhelmingly bullish on the blue chip stock.
According to S&P Global Market Intelligence, the average analyst target price for UNH stock is $639.16, representing implied upside of more than 20% to current levels. Additionally, the consensus recommendation is a Strong Buy.
Financial services firm Oppenheimer has an Outperform rating (equivalent to a Buy) on UNH stock with a $640 price target.
"We believe UNH is well positioned by virtue of its diversification, strong track record, elite management team, and exposure to certain higher growth businesses," wrote Oppenheimer analyst Michael Wiederhorn in a December 5 note.
He adds that UnitedHealth's Optum business "is a nice complement to its core managed care operations and continues to account for a large share of earnings" and its "vertical integration strategy strengthens the company's competitive positioning across many areas of the healthcare landscape."
Related Content
-
New Trump Gambling Loss Deduction Change: Who Pays More Tax Soon?Tax Changes A gambling loss tax deduction change in Trump’s “Big Beautiful Bill” is causing an uproar. Here’s what you need to know.
-
Could a Micro-Retirement Be the Refresh You Need?Don't wait until you turn 65: Why more people are taking "micro-retirements," or short, strategic breaks, years before they retire.
-
What Will the Fed Do at Its Next Meeting?Rate cuts remain on hold this summer, experts say.
-
Take It From a Tax Attorney: This Is a Magic Multimillion-Dollar Tax-Saving StrategyThe qualified small business 1202 stock exemption is a $10 million exclusion that seems too good to be true and is often overlooked.
-
What Would You Like to Leave Behind? A Financial Planner's Guide to Family Wealth DiscussionsCommunicating about your assets and plans for passing them on increases clarity while preventing surprises and family disputes.
-
The Dollar Index Is Sliding. Is Your Portfolio Prepared?The dollar's fall has been troubling because inflation appears to be constrained and the economy has been strong. Here's what it means for investors.
-
Seven Financial Considerations When Downsizing for RetirementWith prices going up on everything, you may be looking for a cheaper place to live. To truly evaluate costs, take a hard look at taxes and intangibles.
-
I Have Plenty of Money: Why Do I Need a Long-Term Care Plan?Long-term care planning, whether through insurance or self-funding, is crucial not only for financial protection but also to preserve family relationships and reduce the emotional and logistical burdens on loved ones.
-
The GENIUS, CLARITY, and Anti-CBDC Acts: What Bitcoin Investors Need to KnowMovement on the crypto front at the federal level has the potential to usher in substantial change. Here's what it means for your portfolio.
-
Wellness Stocks to Invest in NowBreakthroughs that help us live longer, healthier lives can also create opportunities for investors.
